Dezső Schuler

793 total citations
44 papers, 522 citations indexed

About

Dezső Schuler is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dezső Schuler has authored 44 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 14 papers in Pediatrics, Perinatology and Child Health and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dezső Schuler's work include Childhood Cancer Survivors' Quality of Life (12 papers), Glioma Diagnosis and Treatment (12 papers) and Acute Lymphoblastic Leukemia research (11 papers). Dezső Schuler is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (12 papers), Glioma Diagnosis and Treatment (12 papers) and Acute Lymphoblastic Leukemia research (11 papers). Dezső Schuler collaborates with scholars based in Hungary, United Kingdom and United States. Dezső Schuler's co-authors include Miklós Garami, Zsuzsanna Jakab, György Fekete, Péter Hauser, Tamás Révész, P. Kajtár, Tom Révész, Béla Szende, Gábor Borgulya and Gerard Pals and has published in prestigious journals such as The Lancet, Cancer and British Journal of Haematology.

In The Last Decade

Dezső Schuler

42 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dezső Schuler Hungary 13 192 140 133 86 63 44 522
Enrico Brignardello Italy 17 137 0.7× 154 1.1× 267 2.0× 53 0.6× 163 2.6× 34 797
Alireza Moafi Iran 13 94 0.5× 106 0.8× 109 0.8× 106 1.2× 78 1.2× 49 400
Nagore García de Andoín Spain 13 134 0.7× 161 1.1× 124 0.9× 68 0.8× 106 1.7× 22 546
Kamila Kébaïli France 12 109 0.6× 124 0.9× 161 1.2× 170 2.0× 29 0.5× 24 584
Rasoul Pourebrahim Iran 11 222 1.2× 105 0.8× 36 0.3× 113 1.3× 78 1.2× 33 533
Ming Wen United States 10 138 0.7× 51 0.4× 127 1.0× 39 0.5× 112 1.8× 20 554
Mark Rubino United States 10 181 0.9× 44 0.3× 161 1.2× 29 0.3× 97 1.5× 12 641
Shubhada Jagasia United States 11 85 0.4× 54 0.4× 115 0.9× 118 1.4× 64 1.0× 21 486
Yen‐Lin Liu Taiwan 13 177 0.9× 114 0.8× 128 1.0× 12 0.1× 139 2.2× 45 498
Rebecca Crawford United States 11 263 1.4× 44 0.3× 39 0.3× 29 0.3× 73 1.2× 29 602

Countries citing papers authored by Dezső Schuler

Since Specialization
Citations

This map shows the geographic impact of Dezső Schuler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dezső Schuler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dezső Schuler more than expected).

Fields of papers citing papers by Dezső Schuler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dezső Schuler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dezső Schuler. The network helps show where Dezső Schuler may publish in the future.

Co-authorship network of co-authors of Dezső Schuler

This figure shows the co-authorship network connecting the top 25 collaborators of Dezső Schuler. A scholar is included among the top collaborators of Dezső Schuler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dezső Schuler. Dezső Schuler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanzély, Zoltán, et al.. (2008). A szomatosztatinreceptor-expresszió változásának vizsgálata recidiváló medulloblastomában. PubMed. 52(4). 351–355. 1 indexed citations
2.
Ponyi, Andrea, Péter Hauser, Judit Müller, et al.. (2008). Improper Supplementation Habits of Folic Acid Intake by Hungarian Pregnant Women: Improper Recommendations. Journal of the American College of Nutrition. 27(4). 499–504. 3 indexed citations
3.
Hauser, Péter, et al.. (2007). Advanced Pediatric Inoperable Thymus Carcinoma (Type C Thymoma): Case Report on a Novel Therapeutic Approach. Journal of Pediatric Hematology/Oncology. 29(11). 774–775. 7 indexed citations
4.
Dorsman, Josephine C., Marieke Levitus, Davy Rockx, et al.. (2007). Identification of the Fanconi Anemia Complementation Group I Gene, FANCI. Analytical Cellular Pathology. 29(3). 211–218. 101 indexed citations
5.
Hauser, Péter, Zoltán Hanzély, Zsuzsanna Jakab, et al.. (2006). Expression and Prognostic Examination of Heat Shock Proteins (HSP 27, HSP 70, and HSP 90) in Medulloblastoma. Journal of Pediatric Hematology/Oncology. 28(7). 461–466. 9 indexed citations
6.
Garami, Miklós, Dezső Schuler, Gábor Borgulya, et al.. (2004). Fermented Wheat Germ Extract Reduces Chemotherapy-Induced Febrile Neutropenia in Pediatric Cancer Patients. Journal of Pediatric Hematology/Oncology. 26(10). 631–635. 35 indexed citations
7.
Schuler, Dezső & Béla Szende. (2004). Apoptosis in acute leukemia. Leukemia Research. 28(7). 661–666. 17 indexed citations
8.
Hauser, Péter, Zsuzsanna Jakab, Orsolya Láng, et al.. (2003). High incidence of brain tumors of childhood in Hungary between 1989 and 2001. Medical and Pediatric Oncology. 41(6). 590–591. 6 indexed citations
9.
Hauser, Péter, et al.. (2001). Atypical teratoid/rhabdoid tumor or medulloblastoma?. Medical and Pediatric Oncology. 36(6). 644–648. 6 indexed citations
10.
Garami, Miklós, et al.. (2000). [Survival of Ewing' s sarcoma patients in Hungary]. PubMed. 44(4). 261–264. 1 indexed citations
11.
Schuler, Dezső, et al.. (2000). PRACTICE GUIDELINES IN PEDIATRIC HEMATOONCOLOGY: Implementation and Survey. A Possible Way for Medical Quality Assurance. Pediatric Hematology and Oncology. 17(8). 679–685. 2 indexed citations
12.
Schuler, Dezső, et al.. (1998). Effect of etoposide on the pharmacokinetics of methotrexate in vivo. Anti-Cancer Drugs. 9(9). 765–772. 2 indexed citations
13.
Sípos, György, et al.. (1996). Diffuse plasmacytosis in a child with brainstem glioma following multiagent chemotherapy and intensive growth factor support. Medical and Pediatric Oncology. 26(5). 367–371.
14.
Schuler, Dezső, et al.. (1994). Human Recombinant Cranulocyte-Macrophage Colony-Stimulating Factor in Pediatric Oncology Practice. Pediatric Hematology and Oncology. 11(2). 201–205. 4 indexed citations
15.
Masera, Giuseppe, John J. Spinetta, Giulio J. D’Angio, et al.. (1993). SIOP working committee on psychosocial issues in pediatric oncology. Medical and Pediatric Oncology. 21(9). 627–628. 28 indexed citations
18.
Wang, Tao, Yoshiyuki Okano, Randy C. Eisensmith, et al.. (1990). Molecular genetics of PKU in Eastern Europe: A nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somatic Cell and Molecular Genetics. 16(1). 85–90. 32 indexed citations
19.
Schuler, Dezső, et al.. (1988). Methotrexate administered by 6-h and 24-h infusion: a pharmacokinetic comparison. Cancer Chemotherapy and Pharmacology. 22(1). 33–5. 15 indexed citations
20.
Horváth, Károly, et al.. (1985). NALOXONE ANTAGONISES EFFECT OF α-GLIADIN ON LEUCOCYTE MIGRATION IN PATIENTS WITH COELIAC DISEASE. The Lancet. 326(8448). 184–185. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026